News
- Kindred Biosciences Announces Half-Life Extension Technology for Canine AntibodiesJanuary 8, 2020 4:02 PM EST
- Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in DogsDecember 16, 2019 8:02 AM EST
- Kindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight LossDecember 12, 2019 9:05 AM EST
Events
- Wednesday, January 8, 2020 4:30 PM EST
- Thursday, November 21, 2019
- Tuesday, November 19, 2019 from 10:20 AM to 10:50 AM EST
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
SEC Filings
Keyword Search
Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event
Report of unscheduled material events or corporate event
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
CT ORDER
Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event
Report of unscheduled material events or corporate event
Copyright Morningstar